• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于时程的实验设计方法,优化具有胶凝动力学和药物释放特征的亲水性基质配方。

Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles.

机构信息

Department of System Management & Engineering, Inje University, Gimhae 621-749, South Korea.

出版信息

Int J Pharm. 2011 Apr 4;407(1-2):53-62. doi: 10.1016/j.ijpharm.2011.01.013. Epub 2011 Jan 18.

DOI:10.1016/j.ijpharm.2011.01.013
PMID:21251963
Abstract

A new experimental design methodology was developed by integrating the response surface methodology and the time series modeling. The major purposes were to identify significant factors in determining swelling and release rate from matrix tablets and their relative factor levels for optimizing the experimental responses. Properties of tablet swelling and drug release were assessed with ten factors and two default factors, a hydrophilic model drug (terazosin) and magnesium stearate, and compared with target values. The selected input control factors were arranged in a mixture simplex lattice design with 21 experimental runs. The obtained optimal settings for gelation were PEO, LH-11, Syloid, and Pharmacoat with weight ratios of 215.33 (88.50%), 5.68 (2.33%), 19.27 (7.92%), and 3.04 (1.25%), respectively. The optimal settings for drug release were PEO and citric acid with weight ratios of 191.99 (78.91%) and 51.32 (21.09%), respectively. Based on the results of matrix swelling and drug release, the optimal solutions, target values, and validation experiment results over time were similar and showed consistent patterns with very small biases. The experimental design methodology could be a very promising experimental design method to obtain maximum information with limited time and resources. It could also be very useful in formulation studies by providing a systematic and reliable screening method to characterize significant factors in the sustained release matrix tablet.

摘要

一种新的实验设计方法是通过整合响应面法和时间序列建模而开发的。主要目的是确定决定基质片剂溶胀和释放速率的显著因素及其相对因素水平,以优化实验响应。通过 10 个因素和 2 个默认因素(亲水性模型药物(特拉唑嗪)和硬脂酸镁)评估了片剂溶胀和药物释放的性质,并与目标值进行了比较。选择的输入控制因素在具有 21 个实验运行的混合物单纯形格子设计中进行排列。凝胶化的最佳设置分别为 PEO、LH-11、Syloid 和 Pharmacoat,重量比为 215.33(88.50%)、5.68(2.33%)、19.27(7.92%)和 3.04(1.25%)。药物释放的最佳设置分别为 PEO 和柠檬酸,重量比为 191.99(78.91%)和 51.32(21.09%)。基于基质溶胀和药物释放的结果,最佳解决方案、目标值和随时间的验证实验结果相似,表现出一致的模式,偏差很小。该实验设计方法可以是一种非常有前途的实验设计方法,可在有限的时间和资源内获得最大信息。它还可以通过提供系统可靠的筛选方法来表征缓释基质片剂中的显著因素,从而在配方研究中非常有用。

相似文献

1
Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles.基于时程的实验设计方法,优化具有胶凝动力学和药物释放特征的亲水性基质配方。
Int J Pharm. 2011 Apr 4;407(1-2):53-62. doi: 10.1016/j.ijpharm.2011.01.013. Epub 2011 Jan 18.
2
A new experimental design method to optimize formulations focusing on a lubricant for hydrophilic matrix tablets.一种新的实验设计方法,旨在优化亲水基质片剂用润滑剂的配方。
Drug Dev Ind Pharm. 2012 Sep;38(9):1117-27. doi: 10.3109/03639045.2011.641563. Epub 2012 Feb 20.
3
A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets.一种用于考察 PEG 和 PEO 对基质片剂影响的药物稳健性设计方法。
Int J Pharm. 2010 Jun 30;393(1-2):79-87. doi: 10.1016/j.ijpharm.2010.04.009. Epub 2010 Apr 23.
4
A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.一种具有各种层配方和体外释放曲线的新型三层缓释片剂。
Drug Dev Ind Pharm. 2011 Jun;37(6):664-72. doi: 10.3109/03639045.2010.535211. Epub 2011 Mar 30.
5
Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.混合物实验设计在含卡波姆和羟丙甲纤维素的基质片剂的配方和优化中的应用。
Arch Pharm Res. 2009 Dec;32(12):1767-74. doi: 10.1007/s12272-009-2215-9. Epub 2010 Feb 17.
6
A novel experimental design method to optimize hydrophilic matrix formulations with drug release profiles and mechanical properties.一种优化具有药物释放曲线和机械性能的亲水性基质制剂的新型实验设计方法。
J Pharm Sci. 2014 Oct;103(10):3083-94. doi: 10.1002/jps.24080. Epub 2014 Jul 23.
7
Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.亲水性天然胶对盐酸普萘洛尔口服控释骨架片制剂的影响。
Pak J Pharm Sci. 2009 Apr;22(2):211-9.
8
Formulation study and drug release mechanism of a new theophylline sustained-release preparation.一种新型茶碱缓释制剂的处方研究及释药机制
Int J Pharm. 2005 Nov 4;304(1-2):91-101. doi: 10.1016/j.ijpharm.2005.07.022. Epub 2005 Sep 8.
9
Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.具有不同亲水亲脂特性的蔗糖酯:通过直接压缩制备口腔药物输送基质片剂的新型控释剂。
Acta Biomater. 2010 Aug;6(8):3101-9. doi: 10.1016/j.actbio.2010.01.044. Epub 2010 Feb 2.
10
Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.采用多元统计方法优化盐酸地尔硫䓬缓释片制剂,盐酸地尔硫䓬为高水溶性模型药物。
Int J Pharm. 2010 Feb 15;386(1-2):149-55. doi: 10.1016/j.ijpharm.2009.11.008. Epub 2009 Nov 13.

引用本文的文献

1
Introduction of a mathematical model for optimizing the drug release in the patient's body.引入一个数学模型,用于优化患者体内的药物释放。
Daru. 2014 Jan 3;22(1):1. doi: 10.1186/2008-2231-22-1.